PTC Therapeutics, Inc. (PTCT)

68.13 +0.03 (+0.04%) USD  |  NASDAQ  |  Feb 27, 15:11
More

PTC Therapeutics Stock Based Compensation (Annual)

Stock Based Compensation (Annual) Chart

View Stock Based Compensation (Annual) for PTCT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Annual) Range, Past 5 Years

View Stock Based Compensation (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Annual) Benchmarks

View Stock Based Compensation (Annual) Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. Upgrade
Sarepta Therapeutics, Inc. --
Ardelyx, Inc. Upgrade
Spyre Therapeutics, Inc. Upgrade
Ovid Therapeutics, Inc. Upgrade